From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA leans on another compound pharmacy for manufacturing problems

from The Wall Street Journal

Once again, the FDA has taken a tough stance against a compound pharmacy with quality-control problems that led to product recalls and concerns over patient safety. In this latest instance, the agency obtained a consent decree that prohibits Specialty Compounding from making or distributing injectable sterile medicines until the company complies with federal law governing manufacturing practices. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063